CD274 and neoplasm: The role of immune cell recruitment in shaping the response to immunotherapy (i.e., PD-L1 blockade) remains somewhat controversial, as evidence has indicated that the prevailing mechanism is intrinsic to the tumor through the activation of EMT [17,25], while other recent reports have speculated on the essential role of the adaptive immune system [45,46].